Bashan Dror 4
4 · Protalix BioTherapeutics, Inc. · Filed Apr 13, 2022
Insider Transaction Report
Form 4
Bashan Dror
DirectorPRESIDENT AND CEO
Transactions
- Purchase
Common Stock
2022-04-11$1.50/sh+68,000$102,000→ 68,000 total
Holdings
- 1,085,458(indirect: By Trust)
Common Stock
Footnotes (2)
- [F1]The reporting person holds the shares in an account with his spouse as joint tenants.
- [F2]Represents restricted shares of common stock of Protalix BioTherapeutics, Inc., awarded to the employee under its Amended and Restated 2006 Stock Incentive Plan, as amended June 7, 2020. To qualify for certain tax benefits under Section 102 of the Israeli Tax Ordinance, securities issued to an employee in connection with the Plan must be registered in the name of a trustee.